EZETROL

This brand name is authorized in Australia, Austria, Brazil, Canada, Croatia, Cyprus, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Israel, Italy, Lithuania, Malta, Mexico, Netherlands, Poland, Romania, Singapore, South Africa, Spain, Turkey, UK.

Active ingredients

The drug EZETROL contains one active pharmaceutical ingredient (API):

1	Ezetimibe UNII EOR26LQQ24 - EZETIMIBE
	Ezetimibe is in a new class of lipid-lowering compounds that selectively inhibit the intestinal absorption of cholesterol. The molecular target of ezetimibe is the sterol transporter, Niemann-Pick C1-Like 1 (NPC1L1), which is responsible for the intestinal uptake of cholesterol.
	Read more about Ezetimibe

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
EZETROL Tablet	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C10AX09	Ezetimibe	C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AX Other lipid modifying agents
Discover more medicines within C10AX09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	11408K, 8757X
BR	Câmara de Regulação do Mercado de Medicamentos	525500901111216, 525500902116319
CA	Health Products and Food Branch	02247521
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	03209545, 03210086, 05371333, 06198871, 07338937, 07338995, 07339003, 07349823, 08768982, 09434792, 09740767, 10188097, 10339449, 10388092, 10751150, 10978936, 11515960, 11515977, 11515983, 12379950, 12379967, 12379973, 12500334, 13197659, 14256401, 15293290, 15415959, 15415994, 15658219, 16622927, 16812148
EE	Ravimiamet	1162921, 1162932, 1162943, 1162954, 1162965, 1162987, 1162998, 1163001, 1163012, 1205468, 1241389
ES	Centro de información online de medicamentos de la AEMPS	65376, BE249094, BE249094IP, PA-1286-061, PA-1286-061-001, PA1286-061, PL00025-0609, PL00025-0609IP
FI	Lääkealan turvallisuus- ja kehittämiskeskus	013386, 013485
FR	Base de données publique des médicaments	60981789, 62056326, 67841576, 69355352
GB	Medicines & Healthcare Products Regulatory Agency	196124, 44957
HK	Department of Health Drug Office	51223
HR	Agencija za lijekove i medicinske proizvode	HR-H-136569811
IE	Health Products Regulatory Authority	17025, 23263, 23275
IL	מִשְׂרַד הַבְּרִיאוּת	4668
IT	Agenzia del Farmaco	036016145
LT	Valstybinė vaistų kontrolės tarnyba	1004296, 1004297, 1017601, 1017602, 1025402, 1025403, 1053764, 1053765, 1053766, 1053767, 1053768, 1053769, 1053770, 1053771, 1053772, 1053773, 1053774, 1053775, 1053776, 1053777, 1053778, 1053779, 1053780, 1053781, 1053782, 1053783
MT	Medicines Authority	AA1438/00901, AA770/13201, AA908/21901
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	579M2002
NL	Z-Index G-Standaard, PRK	70645
PL	Rejestru Produktów Leczniczych	100137078
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68118001, W68118005, W68118006
SG	Health Sciences Authority	12375P
TR	İlaç ve Tıbbi Cihaz Kurumu	8683280337169
ZA	Health Products Regulatory Authority	37/7.5/0413